Is it significant? As outlined in the editorial by Stecker et al. (2017) in the October issue of Clinical Neurophysiology, there is little difference between the evidence for a p-value slightly less than 0.05 and another slightly larger than 0.05. However, based on a stringent cut-off of a = 0.05, a hypothesis for which p = 0.04 is con-
ventionally accepted as true while, alternatively, with a p = 0.06 is rejected since it is ''not significant". This is a common and uncomfortable ''In-or-Out" scenario, but also every time a test of statistical significance is employed, researchers' interpretation of the study findings would greatly benefit from the valuable data conveyed by confidence intervals. When expressing the results of statistical tests, statisticians stress the importance of using confidence intervals because they convey more information than p values alone (Bland and Peacock, 2002) . In contrast to p-values, which are unitless, confidence intervals have the advantage to reflect the results at the level of data measurement (Altman et al., 2000) , which allows easier interpretation of the findings. While p-values provide a binary measure of the plausibility of a result (du Prel et al., 2009) , that is, rejecting a null hypothesis when it is not true or accepting an alternate hypothesis when it is true, confidence intervals provide information about a range in which the true value lies with a certain degree of probability, which allows statements on direction and strength of the demonstrated effect.
Hence, since the two statistics are not contradictory but complementary, why not reporting both, as specifically required by international initiatives (Moher et al., 2010) aimed at alleviating some of the problems arising from inadequate reporting of the results of clinical trials?
Is it relevant? Clinical neurophysiology deals with the pathophysiology of the nervous system, but before that, it deals with patients. What is considered a significant change for a statistician or for a researcher should be ultimately judged in terms of its clinical relevance for the patient. In therapeutic clinical neurophysiology, we are keen on delivering a wide range of interventions to restore or impact positively on brain function in specific pathological conditions. As a result, we often get p-values that are below the predefined a limit, which make us confident that the findings are statistically significant and allow claiming strong evidence of effect. But, at the end of the day, do patients feel better after our evidence-based interventions? Do they sleep, walk or swim any better? Do they live any better? Maybe, but it looks like most of us are pretty much satisfied with just small p-values. Importantly, the effects of an intervention should be not only statistically but also clinically significant. What is needed is a decision rule for assessing the responsiveness, which is the extent to which change in a measure relates to corresponding change in a reference measure of clinical or health status (Husted et al., 2000; Guyatt et al., 2002) . Such a decision rule is expressed by a number serving as a cutoff score. This score differentiates a meaningful change in an outcome measure from a non-meaningful change, which, even if statistically significant, falls within the so-called error zone. The error (or measurement error) reflects the cumulative effect of the 'subject/patient', 'examiner', 'test instrument', 'protocol', and the 'test environment' factors. One of the most common indicators of responsiveness is the minimal detectable change, which is a statistical estimate of the smallest amount of change detected by a measure, that corresponds to a noticeable change in ability. When taking into account what the patient perceives as relevant, a second indicator is the minimal clinically important difference, also known as the minimal important change, which represents the smallest improvement in score to reflect a change that is clinically meaningful for the patient (Guyatt et al., 2002) . If following an intervention, a change from baseline in an outcome measure exceeds the minimal detectable change or the minimal important change, this variation is considered clinically relevant, otherwise the apparent change, although statistically significant, carries no clinically meaningful value, since it can be attributed to the measurement error. This concept is particularly important when an intervention is introduced, since not every observed significant difference brings a clinical message. For this reason, also clinicians, scholars and researchers in the field of clinical neurophysiology should be aware of clinimetric and responsiveness analyses and incorporate them, along with the measures of effect size, in the comprehensive evaluation of clinical relevance.
